CDH1 and cancer: Dysfunction of E-cadherin is linked to invasiveness and advanced tumor progression in many epithelial cancers, and reduced E-cadherin expression is a hallmark of the epithelial-mesenchymal transition (EMT), while its inhibition provokes detachment and invasion of cancer cells (6,7).